Khi sức mạnh tính toán của AI cũng bắt đầu được "chia sẻ", ai sẽ trở thành người dẫn đầu trong cuộc cạnh tranh mới này?

Cardisio

company

About

Cardisio is a company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases.

  • Frankfurt,Hessen,Germany
  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
€3.50M
Industries
Artificial Intelligence,Fitness,Health Care,Wellness
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Cardisio GmbH.

Cardisio is a mobile health tech company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases. The Cardisiography test can detect heart disease early, allowing for preventive treatment to avoid a potentially fatal heart attack. Cardisiography analyzes the individual three-dimensional electrophysical profile of the heart and recognizes pathological patterns of heart diseases using a proprietary algorithm and neural networks (AI). The test requires a PC to access the web service (Cardisio Cloud), a data collector (e.g. a Cardisiograph), and commercially available ECG cables as well as five disposable electrodes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3.50M
Cardisio has raised a total of €3.50M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2021 Seed €3.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cardisio is funded by 2 investors. Jim Davidson and Shawn O'Neill are the most recent investors.
Investor Name Lead Investor Funding Round
Jim Davidson Seed
Shawn O'Neill Seed

Employee Profiles

Number of Employee Profiles
5
Cardisio has 5 current employee profiles, including Executive Thomas Fechner
Executive
Executive
Executive
Executive